← Scroll for more →
Financial Statements — ABVX
Balance Sheet
(in millions EUR)| Metric | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Cash & Equivalents | 589.70 | 60.95 | 103.58 |
| Total Current Assets | 619.29 | 86.10 | 132.67 |
| Goodwill | 18.42 | 18.42 | 18.42 |
| Total Non-current Assets | 32.76 | 33.54 | 34.27 |
| Total Assets | 652.05 | 119.64 | 166.94 |
| Total Current Liabilities | 78.76 | 112.35 | 105.74 |
| Total Non-current Liabilities | 62.05 | 55.57 | 67.79 |
| Total Liabilities* | 140.81 | 167.92 | 173.53 |
| Total Stockholder Equity | 511.24 | (48.28) | (6.59) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions EUR) (except per-share rows)| Metric | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Research & Development | 55.42 | 38.65 | 39.30 |
| Selling, General & Admin | 25.50 | 8.27 | 8.03 |
| Total Operating Expenses | 82.76 | 47.59 | 48.19 |
| Operating Income | (80.71) | (46.50) | (47.20) |
| Pretax Income | (153.36) | (48.41) | (52.37) |
| Tax Provision | 0.00 | 0.00 | 0.00 |
| Net Income | (153.36) | (48.41) | (52.37) |
| Basic EPS | (2.10) | (0.76) | (0.83) |
| Diluted EPS | (2.10) | (0.76) | (0.83) |
← Scroll for more columns →
Cash Flow Statement
(in millions EUR)| Metric | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Operating Cash Flow | (137.90) | (66.62) | (33.28) |
| Investing Cash Flow | 4.55 | 1.27 | 1.08 |
| Financing Cash Flow | 586.86 | (16.60) | (7.84) |
← Scroll for more columns →